RNAlipid nanoparticle (LNP) vaccines have highlighted the impact of genetic medicines deployed at scale. RNALNP applications include gene editing, oncology, and rare diseases.

A common need for these RNALNP therapies is a scalable manufacturing process, as development of RNALNPs can be time consuming, cost prohibitive and require deep expertise. In a field that is extremely dynamic and accelerating fast, key solutions such as outsourcing can provide direct and valuable access to infrastructure, experience, and meaningful data.

Learn more about BioPharma Services https://www.precisionnanosystems.com/...

Follow us on LinkedIn: https://bit.ly/3F9uEiL
Follow us on Twitter: https://bit.ly/3yBttpW